1.	Phase II Study of Autologous Heat Shock Protein 70 Vaccine in Women With High-Risk Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UCHC-01062, UCHC-1345-01, NCT00027131
2.	Phase I Pilot Study of Vaccination with Mucin Core Peptide and 70-kD Heat-Shock Protein for Resected Pancreatic Adenocarcinoma (Summary Last Modified 07/97) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: MSKCC-96021, NCI-V96-0914
3.	Phase I Study of Vaccination Comprising Tyrosinase and gp100:209-217 Peptides Fused With OVA BiP Peptide and Heat Shock Protein 70 (HSP70) in HLA-A2 Positive Patients With Stage III or IV Melanoma (Summary Last Modified 08/2000) Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: MSKCC-99036, NCI-G00-1771, NCT00005633
4.	Phase I Pilot Study of Autologous Heat Shock Protein 70 in Patients With Chronic Phase Chronic Myelogenous Leukemia Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UCHC-01117, UCHC-7659, NCI-V01-1685, NCT00030303